Alkermes
ALKS
#3093
Rank
A$7.33 B
Marketcap
A$44.44
Share price
0.75%
Change (1 day)
-8.10%
Change (1 year)

Alkermes (ALKS) - Net assets

Net assets on the balance sheet as of September 2025 : A$2.60 Billion

According to Alkermes's latest financial reports the company has A$2.60 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alkermes - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$2.35 B33.42%
2023-12-31$A$1.76 B15.09%
2022-12-31$A$1.53 B-0.06%
2021-12-31$A$1.53 B10.6%
2020-12-31$A$1.38 B-10.49%
2019-12-31$A$1.55 B-6.76%
2018-12-31$A$1.66 B7.92%
2017-12-31$A$1.54 B-8.18%
2016-12-31$A$1.67 B-6.99%
2015-12-31$A$1.80 B5.7%
2014-12-31$A$1.70 B
2013-03-31$A$0.91 B11.2%
2012-03-31$A$0.82 B116.83%
2011-03-31$A$0.37 B-15.36%
2010-03-31$A$0.44 B-27.96%
2009-03-31$A$0.62 B87.69%
2008-03-31$A$0.33 B31.63%
2007-03-31$A$0.25 B435.12%
2006-03-31$A$47.05 M784.37%
2005-03-31$A$5.32 M-94.72%
2004-03-31$A$0.10 B-1304.78%
2003-03-31$-A$8.37 Million-104.48%
2002-03-31$A$0.18 B-39.17%
2001-03-31$A$0.30 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Acorda Therapeutics
ACOR
-A$0.28 Billion-110.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B 973.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B 4,473.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 5,270.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$69.20 B 2,552.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$10.92 B 318.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
A$129.92 B 4,878.41%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$67.37 B 2,481.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland